Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Verona Pharma plc Director's Dealing 2023

Sep 5, 2023

30667_dirs_2023-09-05_cd1c620a-ebe5-4632-ae64-fed567f4eb4e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Verona Pharma plc (VRNA)
CIK: 0001657312
Period of Report: 2023-09-01

Reporting Person: ACKERMANN CHRISTINA (Director)

More from Verona Pharma plc

Regulatory Filings 2025
Nov 17
Major Shareholding Notification 2025
Nov 14
Major Shareholding Notification 2025
Nov 14
Major Shareholding Notification 2025
Oct 17
Regulatory Filings 2025
Oct 17
Director's Dealing 2025
Oct 8
Director's Dealing 2025
Oct 8
Director's Dealing 2025
Oct 8
Director's Dealing 2025
Oct 8
Director's Dealing 2025
Oct 8
View all filings →